Literature DB >> 2242756

A new surface antigen on intraepithelial lymphocytes in the intestine.

P J Kilshaw1, S J Murant.   

Abstract

A new surface molecule has been discovered on mouse intestinal intraepithelial lymphocytes (IEL) using a rat anti-mouse IEL monoclonal antibody, M290. It was expressed at high levels on nearly all IEL and on a majority of T cells in the gut lamina propria. M290 stained, with lower intensity, a small minority of T cells in other lymphoid tissues. Expression was biased towards the CD8+ subset. Stimulation of peripheral T cells with mitogens did not induce expression of the new antigen but addition of transforming growth factor beta to stimulated T cells had a marked inductive effect. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis of IEL surface components precipitated with M290 showed principal bands at 135, 120, 28 and 24 kDa (reduced) and 135, 100, 24 and 21 kDa (nonreduced). Precipitation with antibodies to integrin subunits showed that the new molecular complex was not a member of the beta 1, beta 2, or beta 3 integrin families although all of these were represented on IEL. A 13-amino acid N-terminal sequence obtained from the 120-kDa beta subunit of the antigen prepared from an M290+ T hybridoma (MTC-1) did not show homology with integrins. Pulse-chase studies using MTC-1 cells showed that the 135-kDa alpha subunit was derived from a 147-kDa precursor. The function of this new molecular complex is not yet known.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242756     DOI: 10.1002/eji.1830201008

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  66 in total

Review 1.  Alpha E beta 7.

Authors:  P J Kilshaw
Journal:  Mol Pathol       Date:  1999-08

Review 2.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 3.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

4.  Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.

Authors:  R Dolcetti; R Giardini; C Doglioni; R Cariati; F Pomponi; C D'Orazi; S Rao; A I Lazarovits; E C Butcher; M Boiocchi
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

5.  Genetic mapping of the gene coding for the integrin beta 7 subunit to the distal part of mouse chromosome 15.

Authors:  Q Yuan; C A Kozak; W M Jiang; D Hollander; J D Watson; G W Krissansen
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  A family of beta 7 integrins on human mucosal lymphocytes.

Authors:  C M Parker; K L Cepek; G J Russell; S K Shaw; D N Posnett; R Schwarting; M B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

7.  Mapping of the human integrin beta 7 gene (ITG beta 7) to 12q13.13 by non-isotopic in situ hybridization.

Authors:  E Baker; G R Sutherland; W M Jiang; Q Yuan; E Leung; J D Watson; G W Krissansen
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

8.  The αE(CD103)β7 integrin interacts with oral and skin keratinocytes in an E-cadherin-independent manner*.

Authors:  Sarah E Jenkinson; Simon A Whawell; Brenka M Swales; Elaine M Corps; Peter J Kilshaw; Paula M Farthing
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

9.  Chromosomal locations of the genes coding for the integrin beta 6 and beta 7 subunits.

Authors:  G W Krissansen; Q Yuan; D Jenkins; W M Jiang; L Rooke; N K Spurr; M Eccles; E Leung; J D Watson
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice.

Authors:  A Ma; M Datta; E Margosian; J Chen; I Horak
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.